1005 related articles for article (PubMed ID: 22972111)
21. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD004318. PubMed ID: 30916777
[TBL] [Abstract][Full Text] [Related]
22. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
[TBL] [Abstract][Full Text] [Related]
23. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Hamulyák EN; Scheres LJ; Marijnen MC; Goddijn M; Middeldorp S
Cochrane Database Syst Rev; 2020 May; 5(5):CD012852. PubMed ID: 32358837
[TBL] [Abstract][Full Text] [Related]
24. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD004318. PubMed ID: 30481366
[TBL] [Abstract][Full Text] [Related]
25. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism.
van Dongen CJ; van den Belt AG; Prins MH; Lensing AW
Cochrane Database Syst Rev; 2004 Oct; (4):CD001100. PubMed ID: 15495007
[TBL] [Abstract][Full Text] [Related]
26. Anticoagulation for the initial treatment of venous thromboembolism in people with cancer.
Kahale LA; Matar CF; Hakoum MB; Tsolakian IG; Yosuico VE; Terrenato I; Sperati F; Barba M; Schünemann H; Akl EA
Cochrane Database Syst Rev; 2021 Dec; 12(12):CD006649. PubMed ID: 34878173
[TBL] [Abstract][Full Text] [Related]
27. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
Di Nisio M; Porreca E; Ferrante N; Otten HM; Cuccurullo F; Rutjes AW
Cochrane Database Syst Rev; 2012 Feb; (2):CD008500. PubMed ID: 22336844
[TBL] [Abstract][Full Text] [Related]
28. Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair.
Forster R; Stewart M
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD004179. PubMed ID: 27027384
[TBL] [Abstract][Full Text] [Related]
29. WITHDRAWN: Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction).
Alikhan R; Cohen AT
Cochrane Database Syst Rev; 2010 Feb; (2):CD003747. PubMed ID: 20166070
[TBL] [Abstract][Full Text] [Related]
30. Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction).
Alikhan R; Cohen AT
Cochrane Database Syst Rev; 2009 Jul; (3):CD003747. PubMed ID: 19588346
[TBL] [Abstract][Full Text] [Related]
31. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.
Chande N; McDonald JW; Macdonald JK
Cochrane Database Syst Rev; 2008 Apr; (2):CD006774. PubMed ID: 18425969
[TBL] [Abstract][Full Text] [Related]
32. [Heparin-induced thrombocytopenia as a complication of postoperative prevention of thromboembolism with unfractionated heparin/low molecular weight heparin after hip and knee prosthesis implantation].
Mahlfeld K; Franke J; Schaeper O; Kayser R; Grasshoff H
Unfallchirurg; 2002 Apr; 105(4):327-31. PubMed ID: 12066471
[TBL] [Abstract][Full Text] [Related]
33. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Warkentin TE; Greinacher A
Chest; 2004 Sep; 126(3 Suppl):311S-337S. PubMed ID: 15383477
[TBL] [Abstract][Full Text] [Related]
34. Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction).
Alikhan R; Bedenis R; Cohen AT
Cochrane Database Syst Rev; 2014 May; 2014(5):CD003747. PubMed ID: 24804622
[TBL] [Abstract][Full Text] [Related]
35. Pentasaccharides for the treatment of deep vein thrombosis.
Brandao GM; Junqueira DR; Rollo HA; Sobreira ML
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011782. PubMed ID: 29199766
[TBL] [Abstract][Full Text] [Related]
36. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
[TBL] [Abstract][Full Text] [Related]
37. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD004318. PubMed ID: 31449321
[TBL] [Abstract][Full Text] [Related]
38. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
Di Nisio M; Porreca E; Candeloro M; De Tursi M; Russi I; Rutjes AW
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD008500. PubMed ID: 27906452
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and Safety of Low Molecular Weight Heparin Versus Unfractionated Heparin for Prevention of Venous Thromboembolism in Trauma Patients: A Systematic Review and Meta-analysis.
Tran A; Fernando SM; Carrier M; Siegal DM; Inaba K; Vogt K; Engels PT; English SW; Kanji S; Kyeremanteng K; Lampron J; Kim D; Rochwerg B
Ann Surg; 2022 Jan; 275(1):19-28. PubMed ID: 34387202
[TBL] [Abstract][Full Text] [Related]
40. Anticoagulation for the initial treatment of venous thromboembolism in people with cancer.
Hakoum MB; Kahale LA; Tsolakian IG; Matar CF; Yosuico VE; Terrenato I; Sperati F; Barba M; Schünemann H; Akl EA
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD006649. PubMed ID: 29363105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
